Kadouri L - Search Results

1

SYK expression level distinguishes control from BRCA1-mutated lymphocytes.

Zahavi T, Sonnenblick A, Shimshon Y, Kadouri L, Peretz T, Salmon AY, Salmon-Divon M. Zahavi T, et al. Among authors: kadouri l. Cancer Manag Res. 2018 Mar 26;10:589-598. doi: 10.2147/CMAR.S156359. eCollection 2018. Cancer Manag Res. 2018. PMID: 29618939 Free PMC article.

2

[Genetic counseling for families at high cancer risk].

Sagi M, Heching N, Kadouri L, Abeliovich D, Zlotogora J, Bach G, Peretz T. Sagi M, et al. Among authors: kadouri l. Harefuah. 1996 Apr 1;130(7):441-6, 504. Harefuah. 1996. PMID: 8707209 Hebrew.

3

A deletion/insertion mutation in the BRCA2 gene in a breast cancer family: a possible role of the Alu-polyA tail in the evolution of the deletion.

Wang T, Lerer I, Gueta Z, Sagi M, Kadouri L, Peretz T, Abeliovich D. Wang T, et al. Among authors: kadouri l. Genes Chromosomes Cancer. 2001 May;31(1):91-5. doi: 10.1002/gcc.1110. Genes Chromosomes Cancer. 2001. PMID: 11284040

4

CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers.

Kadouri L, Easton DF, Edwards S, Hubert A, Kote-Jarai Z, Glaser B, Durocher F, Abeliovich D, Peretz T, Eeles RA. Kadouri L, et al. Br J Cancer. 2001 Jul 6;85(1):36-40. doi: 10.1054/bjoc.2001.1777. Br J Cancer. 2001. PMID: 11437399 Free PMC article.

5

A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews.

Rennert H, Bercovich D, Hubert A, Abeliovich D, Rozovsky U, Bar-Shira A, Soloviov S, Schreiber L, Matzkin H, Rennert G, Kadouri L, Peretz T, Yaron Y, Orr-Urtreger A. Rennert H, et al. Among authors: kadouri l. Am J Hum Genet. 2002 Oct;71(4):981-4. doi: 10.1086/342775. Epub 2002 Jul 23. Am J Hum Genet. 2002. PMID: 12145743 Free PMC article.

6

Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma.

Nachmias B, Ashhab Y, Bucholtz V, Drize O, Kadouri L, Lotem M, Peretz T, Mandelboim O, Ben-Yehuda D. Nachmias B, et al. Among authors: kadouri l. Cancer Res. 2003 Oct 1;63(19):6340-9. Cancer Res. 2003. PMID: 14559822

7

Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers.

Kadouri L, Kote-Jarai Z, Easton DF, Hubert A, Hamoudi R, Glaser B, Abeliovich D, Peretz T, Eeles RA. Kadouri L, et al. Int J Cancer. 2004 Jan 20;108(3):399-403. doi: 10.1002/ijc.11531. Int J Cancer. 2004. PMID: 14648706 Free article.

8

A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers.

Kadouri L, Kote-Jarai Z, Hubert A, Durocher F, Abeliovich D, Glaser B, Hamburger T, Eeles RA, Peretz T. Kadouri L, et al. Br J Cancer. 2004 May 17;90(10):2002-5. doi: 10.1038/sj.bjc.6601837. Br J Cancer. 2004. PMID: 15138485 Free PMC article.

9

A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer.

Kadouri L, Bercovich D, Elimelech A, Lerer I, Sagi M, Glusman G, Shochat C, Korem S, Hamburger T, Nissan A, Abu-Halaf N, Badrriyah M, Abeliovich D, Peretz T. Kadouri L, et al. BMC Cancer. 2007 Jan 18;7:14. doi: 10.1186/1471-2407-7-14. BMC Cancer. 2007. PMID: 17233897 Free PMC article.

10

Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations.

Kadouri L, Hubert A, Rotenberg Y, Hamburger T, Sagi M, Nechushtan C, Abeliovich D, Peretz T. Kadouri L, et al. J Med Genet. 2007 Jul;44(7):467-71. doi: 10.1136/jmg.2006.048173. Epub 2007 Feb 16. J Med Genet. 2007. PMID: 17307836 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page